Table 1 Clinical characteristics of enrolled subjects
Overall | CHB | LC | HCC | P | ||
|---|---|---|---|---|---|---|
n | 175 | 61 | 57 | 57 | ||
Age (mean (SD)) | 57.74 (9.80) | 57.79 (8.94) | 56.39 (9.85) | 59.05 (10.60) | 0.35 | |
Sex, n (%) | Male | 131(74.86) | 47(77.05) | 40(70.18) | 44(77.19) | 0.611 |
Female | 44(25.14) | 14(22.95) | 17(29.82) | 13(22.81) | ||
HBsAg (%) | missing | 1 (0.6) | 0 (0.0) | 1 (1.8) | 0 (0.0) | 0.489 |
- | 14 (8.0) | 3 (4.9) | 5 (8.8) | 6 (10.5) | ||
+ | 160 (91.4) | 58 (95.1) | 51 (89.5) | 51 (89.5) | ||
HBcAb (%) | missing | 1 (0.6) | 0 (0.0) | 1 (1.8) | 0 (0.0) | 0.271 |
- | 5 (2.9) | 0 (0.0) | 2 (3.5) | 3 (5.3) | ||
+ | 169 (96.6) | 61 (100.0) | 54 (94.7) | 54 (94.7) | ||
AFP (ng/mL), median [IQR] | 2.45 [1.60, 4.64] | 2.29 [1.39, 2.73] | 2.50 [1.80, 4.60] | 3.30 [1.68, 34.40] | 0.007 | |
CNLC stage | I | 38(66.7) | ||||
II | 12(21.1) | |||||
III | 6(10.5) | |||||
IV | 1(1.8) | |||||